Is DocuSign Stock Undervalued?
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
Sell
25
SKHCF Quote, Financials, Valuation and Earnings
Last price:
$14.08
Seasonality move
:
1.13%
Day range:
$14.08 - $14.08
52-week range:
$12.70 - $19.34
Dividend yield:
0%
P/E ratio:
20.41x
P/S ratio:
1.10x
P/B ratio:
1.61x
Volume:
743
Avg. volume:
7.2K
1-year change:
-21.43%
Market cap:
$7B
Revenue:
$6.1B
EPS (TTM):
$0.69
Price Performance History
Performance vs. Valuation Benchmarks
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Competitors
| Company | Revenue Forecast | Earnings Forecast | Revenue Growth Forecast | Earnings Growth Forecast | Analyst Price Target Median |
|---|---|---|---|---|---|
|
SKHCF
Sonic Healthcare Ltd.
|
-- | -- | -- | -- | -- |
|
ATHE
Alterity Therapeutics Ltd.
|
-- | -- | -- | -- | $12.00 |
|
IMMP
Immutep Ltd.
|
-- | -- | -- | -- | $9.50 |
|
KZIA
Kazia Therapeutics Ltd.
|
-- | -- | -- | -- | $19.01 |
|
MESO
Mesoblast Ltd.
|
$24.8M | -- | -100% | -- | $35.00 |
|
PPCB
|
-- | -- | -- | -- | -- |
| Company | Price | Analyst Target | Market Cap | P/E Ratio | Dividend per Share | Dividend Yield | Price / LTM Sales |
|---|---|---|---|---|---|---|---|
|
SKHCF
Sonic Healthcare Ltd.
|
$14.08 | -- | $7B | 20.41x | $0.28 | 0% | 1.10x |
|
ATHE
Alterity Therapeutics Ltd.
|
$3.17 | $12.00 | $57.5M | -- | $0.00 | 0% | 3.58x |
|
IMMP
Immutep Ltd.
|
$3.13 | $9.50 | $455.6M | -- | $0.00 | 0% | -- |
|
KZIA
Kazia Therapeutics Ltd.
|
$7.57 | $19.01 | $12.6M | -- | $0.00 | 0% | 342.04x |
|
MESO
Mesoblast Ltd.
|
$19.50 | $35.00 | $2.5B | -- | $0.00 | 0% | 136.85x |
|
PPCB
|
$11.98 | -- | $158.1K | -- | $0.00 | 0% | -- |
| Company | Total Debt / Total Capital | Beta | Debt to Equity | Quick Ratio |
|---|---|---|---|---|
|
SKHCF
Sonic Healthcare Ltd.
|
36.93% | 0.454 | -- | 0.84x |
|
ATHE
Alterity Therapeutics Ltd.
|
-- | -1.575 | -- | -- |
|
IMMP
Immutep Ltd.
|
-- | 0.640 | -- | -- |
|
KZIA
Kazia Therapeutics Ltd.
|
-6.76% | 5.445 | 5.57% | 0.07x |
|
MESO
Mesoblast Ltd.
|
-- | 0.345 | -- | -- |
|
PPCB
|
-- | 4.794 | -- | -- |
| Company | Gross Profit | Operating Income | Return on Invested Capital | Return on Common Equity | EBIT Margin | Free Cash Flow |
|---|---|---|---|---|---|---|
|
SKHCF
Sonic Healthcare Ltd.
|
-- | -- | 4.54% | 6.72% | -- | -- |
|
ATHE
Alterity Therapeutics Ltd.
|
-- | -- | -- | -- | -- | -- |
|
IMMP
Immutep Ltd.
|
-- | -- | -- | -- | -- | -- |
|
KZIA
Kazia Therapeutics Ltd.
|
-- | -- | -784.09% | -1083.16% | -- | -- |
|
MESO
Mesoblast Ltd.
|
-- | -- | -- | -- | -- | -- |
|
PPCB
|
-- | -$290.8K | -- | -- | -- | -$235.5K |
Sonic Healthcare Ltd. vs. Competitors
-
Which has Higher Returns SKHCF or ATHE?
Alterity Therapeutics Ltd. has a net margin of -- compared to Sonic Healthcare Ltd.'s net margin of --. Sonic Healthcare Ltd.'s return on equity of 6.72% beat Alterity Therapeutics Ltd.'s return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital SKHCFSonic Healthcare Ltd.-- -- $8.2B ATHEAlterity Therapeutics Ltd.-- -- -- -
What do Analysts Say About SKHCF or ATHE?
Sonic Healthcare Ltd. has a consensus price target of --, signalling downside risk potential of --. On the other hand Alterity Therapeutics Ltd. has an analysts' consensus of $12.00 which suggests that it could grow by 278.55%. Given that Alterity Therapeutics Ltd. has higher upside potential than Sonic Healthcare Ltd., analysts believe Alterity Therapeutics Ltd. is more attractive than Sonic Healthcare Ltd..
Company Buy Ratings Hold Ratings Sell Ratings SKHCFSonic Healthcare Ltd.0 0 0 ATHEAlterity Therapeutics Ltd.0 0 0 -
Is SKHCF or ATHE More Risky?
Sonic Healthcare Ltd. has a beta of 0.978, which suggesting that the stock is 2.167% less volatile than S&P 500. In comparison Alterity Therapeutics Ltd. has a beta of 0.023, suggesting its less volatile than the S&P 500 by 97.656%.
-
Which is a Better Dividend Stock SKHCF or ATHE?
Sonic Healthcare Ltd. has a quarterly dividend of $0.28 per share corresponding to a yield of 0%. Alterity Therapeutics Ltd. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Sonic Healthcare Ltd. pays 100.05% of its earnings as a dividend. Alterity Therapeutics Ltd. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios SKHCF or ATHE?
Sonic Healthcare Ltd. quarterly revenues are --, which are smaller than Alterity Therapeutics Ltd. quarterly revenues of --. Sonic Healthcare Ltd.'s net income of -- is lower than Alterity Therapeutics Ltd.'s net income of --. Notably, Sonic Healthcare Ltd.'s price-to-earnings ratio is 20.41x while Alterity Therapeutics Ltd.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Sonic Healthcare Ltd. is 1.10x versus 3.58x for Alterity Therapeutics Ltd.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income SKHCFSonic Healthcare Ltd.1.10x 20.41x -- -- ATHEAlterity Therapeutics Ltd.3.58x -- -- --
-
Which has Higher Returns SKHCF or IMMP?
Immutep Ltd. has a net margin of -- compared to Sonic Healthcare Ltd.'s net margin of --. Sonic Healthcare Ltd.'s return on equity of 6.72% beat Immutep Ltd.'s return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital SKHCFSonic Healthcare Ltd.-- -- $8.2B IMMPImmutep Ltd.-- -- -- -
What do Analysts Say About SKHCF or IMMP?
Sonic Healthcare Ltd. has a consensus price target of --, signalling downside risk potential of --. On the other hand Immutep Ltd. has an analysts' consensus of $9.50 which suggests that it could grow by 203.51%. Given that Immutep Ltd. has higher upside potential than Sonic Healthcare Ltd., analysts believe Immutep Ltd. is more attractive than Sonic Healthcare Ltd..
Company Buy Ratings Hold Ratings Sell Ratings SKHCFSonic Healthcare Ltd.0 0 0 IMMPImmutep Ltd.1 0 0 -
Is SKHCF or IMMP More Risky?
Sonic Healthcare Ltd. has a beta of 0.978, which suggesting that the stock is 2.167% less volatile than S&P 500. In comparison Immutep Ltd. has a beta of 1.925, suggesting its more volatile than the S&P 500 by 92.469%.
-
Which is a Better Dividend Stock SKHCF or IMMP?
Sonic Healthcare Ltd. has a quarterly dividend of $0.28 per share corresponding to a yield of 0%. Immutep Ltd. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Sonic Healthcare Ltd. pays 100.05% of its earnings as a dividend. Immutep Ltd. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios SKHCF or IMMP?
Sonic Healthcare Ltd. quarterly revenues are --, which are smaller than Immutep Ltd. quarterly revenues of --. Sonic Healthcare Ltd.'s net income of -- is lower than Immutep Ltd.'s net income of --. Notably, Sonic Healthcare Ltd.'s price-to-earnings ratio is 20.41x while Immutep Ltd.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Sonic Healthcare Ltd. is 1.10x versus -- for Immutep Ltd.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income SKHCFSonic Healthcare Ltd.1.10x 20.41x -- -- IMMPImmutep Ltd.-- -- -- --
-
Which has Higher Returns SKHCF or KZIA?
Kazia Therapeutics Ltd. has a net margin of -- compared to Sonic Healthcare Ltd.'s net margin of --. Sonic Healthcare Ltd.'s return on equity of 6.72% beat Kazia Therapeutics Ltd.'s return on equity of -1083.16%.
Company Gross Margin Earnings Per Share Invested Capital SKHCFSonic Healthcare Ltd.-- -- $8.2B KZIAKazia Therapeutics Ltd.-- -- -$6.3M -
What do Analysts Say About SKHCF or KZIA?
Sonic Healthcare Ltd. has a consensus price target of --, signalling downside risk potential of --. On the other hand Kazia Therapeutics Ltd. has an analysts' consensus of $19.01 which suggests that it could grow by 151.57%. Given that Kazia Therapeutics Ltd. has higher upside potential than Sonic Healthcare Ltd., analysts believe Kazia Therapeutics Ltd. is more attractive than Sonic Healthcare Ltd..
Company Buy Ratings Hold Ratings Sell Ratings SKHCFSonic Healthcare Ltd.0 0 0 KZIAKazia Therapeutics Ltd.1 0 0 -
Is SKHCF or KZIA More Risky?
Sonic Healthcare Ltd. has a beta of 0.978, which suggesting that the stock is 2.167% less volatile than S&P 500. In comparison Kazia Therapeutics Ltd. has a beta of 1.672, suggesting its more volatile than the S&P 500 by 67.185%.
-
Which is a Better Dividend Stock SKHCF or KZIA?
Sonic Healthcare Ltd. has a quarterly dividend of $0.28 per share corresponding to a yield of 0%. Kazia Therapeutics Ltd. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Sonic Healthcare Ltd. pays 100.05% of its earnings as a dividend. Kazia Therapeutics Ltd. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios SKHCF or KZIA?
Sonic Healthcare Ltd. quarterly revenues are --, which are smaller than Kazia Therapeutics Ltd. quarterly revenues of --. Sonic Healthcare Ltd.'s net income of -- is lower than Kazia Therapeutics Ltd.'s net income of --. Notably, Sonic Healthcare Ltd.'s price-to-earnings ratio is 20.41x while Kazia Therapeutics Ltd.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Sonic Healthcare Ltd. is 1.10x versus 342.04x for Kazia Therapeutics Ltd.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income SKHCFSonic Healthcare Ltd.1.10x 20.41x -- -- KZIAKazia Therapeutics Ltd.342.04x -- -- --
-
Which has Higher Returns SKHCF or MESO?
Mesoblast Ltd. has a net margin of -- compared to Sonic Healthcare Ltd.'s net margin of --. Sonic Healthcare Ltd.'s return on equity of 6.72% beat Mesoblast Ltd.'s return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital SKHCFSonic Healthcare Ltd.-- -- $8.2B MESOMesoblast Ltd.-- -- -- -
What do Analysts Say About SKHCF or MESO?
Sonic Healthcare Ltd. has a consensus price target of --, signalling downside risk potential of --. On the other hand Mesoblast Ltd. has an analysts' consensus of $35.00 which suggests that it could grow by 79.49%. Given that Mesoblast Ltd. has higher upside potential than Sonic Healthcare Ltd., analysts believe Mesoblast Ltd. is more attractive than Sonic Healthcare Ltd..
Company Buy Ratings Hold Ratings Sell Ratings SKHCFSonic Healthcare Ltd.0 0 0 MESOMesoblast Ltd.1 0 0 -
Is SKHCF or MESO More Risky?
Sonic Healthcare Ltd. has a beta of 0.978, which suggesting that the stock is 2.167% less volatile than S&P 500. In comparison Mesoblast Ltd. has a beta of 2.025, suggesting its more volatile than the S&P 500 by 102.508%.
-
Which is a Better Dividend Stock SKHCF or MESO?
Sonic Healthcare Ltd. has a quarterly dividend of $0.28 per share corresponding to a yield of 0%. Mesoblast Ltd. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Sonic Healthcare Ltd. pays 100.05% of its earnings as a dividend. Mesoblast Ltd. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios SKHCF or MESO?
Sonic Healthcare Ltd. quarterly revenues are --, which are smaller than Mesoblast Ltd. quarterly revenues of --. Sonic Healthcare Ltd.'s net income of -- is lower than Mesoblast Ltd.'s net income of --. Notably, Sonic Healthcare Ltd.'s price-to-earnings ratio is 20.41x while Mesoblast Ltd.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Sonic Healthcare Ltd. is 1.10x versus 136.85x for Mesoblast Ltd.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income SKHCFSonic Healthcare Ltd.1.10x 20.41x -- -- MESOMesoblast Ltd.136.85x -- -- --
-
Which has Higher Returns SKHCF or PPCB?
has a net margin of -- compared to Sonic Healthcare Ltd.'s net margin of --. Sonic Healthcare Ltd.'s return on equity of 6.72% beat 's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital SKHCFSonic Healthcare Ltd.-- -- $8.2B PPCB-- -$0.00 -- -
What do Analysts Say About SKHCF or PPCB?
Sonic Healthcare Ltd. has a consensus price target of --, signalling downside risk potential of --. On the other hand has an analysts' consensus of -- which suggests that it could fall by --. Given that Sonic Healthcare Ltd. has higher upside potential than , analysts believe Sonic Healthcare Ltd. is more attractive than .
Company Buy Ratings Hold Ratings Sell Ratings SKHCFSonic Healthcare Ltd.0 0 0 PPCB0 0 0 -
Is SKHCF or PPCB More Risky?
Sonic Healthcare Ltd. has a beta of 0.978, which suggesting that the stock is 2.167% less volatile than S&P 500. In comparison has a beta of 1.881, suggesting its more volatile than the S&P 500 by 88.104%.
-
Which is a Better Dividend Stock SKHCF or PPCB?
Sonic Healthcare Ltd. has a quarterly dividend of $0.28 per share corresponding to a yield of 0%. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Sonic Healthcare Ltd. pays 100.05% of its earnings as a dividend. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios SKHCF or PPCB?
Sonic Healthcare Ltd. quarterly revenues are --, which are smaller than quarterly revenues of --. Sonic Healthcare Ltd.'s net income of -- is lower than 's net income of -$354.3K. Notably, Sonic Healthcare Ltd.'s price-to-earnings ratio is 20.41x while 's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Sonic Healthcare Ltd. is 1.10x versus -- for . Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income SKHCFSonic Healthcare Ltd.1.10x 20.41x -- -- PPCB-- -- -- -$354.3K
Related Companies
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is SentinelOne Stock Undervalued?
Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…
Is Broadcom Stock on Sale?
Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…
Stock Ideas
Buy
59
Is NVDA Stock a Buy?
Market Cap: $4.6T
P/E Ratio: 65x
Buy
55
Is AAPL Stock a Buy?
Market Cap: $4T
P/E Ratio: 37x
Buy
61
Is GOOG Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 39x
Alerts
Buy
72
GLTO alert for Dec 27
Galecto, Inc. [GLTO] is up 16.92% over the past day.
Sell
20
SMX alert for Dec 27
SMX (Security Matters) Plc [SMX] is down 15.76% over the past day.
Sell
11
CDNAF alert for Dec 27
Canadian Tire Corp. Ltd. [CDNAF] is down 10% over the past day.
